Skip to Content

Drug Interactions between Tivicay and Viramune

This report displays the potential drug interactions for the following 2 drugs:

  • Tivicay (dolutegravir)
  • Viramune (nevirapine)

Edit list (add/remove drugs)

Interactions between your drugs


nevirapine dolutegravir

Applies to: Viramune (nevirapine) and Tivicay (dolutegravir)

Talk to your doctor before using nevirapine together with dolutegravir. Combining these medications may reduce the blood levels of dolutegravir, which may make the medication less effective in treating HIV infection. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition worsens or you develop new infections during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions


dolutegravir food

Applies to: Tivicay (dolutegravir)

Information for this minor interaction is only available at a professional reading level.

For clinical details see professional interaction data.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.